Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04675190Completed

Major Surgery as a Risk of Gall Stone Disease?

Role: collaborator

NCT03427502Not ApplicableCompleted

Anterior Ethmoidal Nerve Block in Prevention of Postoperative Agitation

Role: lead

NCT03590912Phase 4Completed

Efficacy and Cost Analysis of Steroids in Treatment of Otitis Media With Effusion

Role: lead

NCT03620513Phase 4Completed

Pretreatment to Reduce Pain and Discomfort During Fiberoptic Nasal Pharyngoscopy and Laryngoscopy

Role: lead

NCT04213092Completed

Single Setting ERCP and Laparoscopic Cholecystectomy is a Safe Procedure in Patients With Cholecysto-Choledocholithiasis

Role: lead

All 5 trials loaded